Company / Net Income
Bone Biologics Corp Net Income History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$3.4M
FY2020
5-year range
-$17.0M / -$3.4M
FY2017-FY2020
Trend
+22.7%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has increased for 3 consecutive years, from -$17M in FY2017 to -$3M in FY2020.
Based on SEC 10-K filings.
-$3M in FY2020.
Improved from -$7M to -$3M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Bone Biologics Corp's net income has grown for 3 consecutive years.
- In FY2020, net income increased 22.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$3.4M | +22.7% |
| FY2019 | -$4.4M | +37.2% |
| FY2018 | -$7.1M | +58.4% |
| FY2017 | -$17.0M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026